Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Short-term in vitro sensitivity testing in acute leukemia.

J D Schwarzmeier, R Pirker, E Paietta

    Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
    |January 1, 1984
    PubMed
    Summary

    This study developed a short-term assay to predict leukemia patient response to chemotherapy. The in vitro drug sensitivity test accurately reflected clinical outcomes for doxorubicin and ara-C, aiding treatment decisions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    New onset of systemic lupus erythematosus following COVID-19 mRNA vaccination.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2023
    Same author

    Hyperprogression of Merkel cell carcinoma after avelumab treatment.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2023
    Same author

    Conquering lung cancer: current status and prospects for the future.

    Pulmonology·2020
    Same author

    [Strategies to Overcome Acquired Resistance to EGFR-TKI Therapy Based on T790M Specific Substances using Osimertinib as an Example].

    Pneumologie (Stuttgart, Germany)·2018
    Same author

    The evolving role of chemotherapy and hematopoietic cell transplants in Ph-positive acute lymphoblastic leukemia in adults.

    Bone marrow transplantation·2017
    Same author

    PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017

    Area of Science:

    • Oncology
    • Pharmacology
    • Cell Biology

    Background:

    • Predicting patient response to chemotherapy is crucial for effective acute leukemia treatment.
    • Assessing leukemic cell sensitivity to cytostatic agents prior to therapy can optimize treatment strategies.

    Purpose of the Study:

    • To evaluate a short-term in vitro incubation method for detecting leukemic cell sensitivity or resistance to chemotherapy before treatment.
    • To correlate in vitro drug responsiveness with clinical outcomes in acute leukemia patients.

    Main Methods:

    • Blast cells from acute leukemia patients were incubated with cytostatic agents (doxorubicin, ara-C).
    • In vitro drug sensitivity was measured by the suppression of nucleoside precursor (3H-uridine, 3H-deoxyuridine) incorporation.
    • In vitro results were retrospectively compared to patient responses to polychemotherapy.

    Related Experiment Videos

    Main Results:

    • The in vitro cytotoxic effectiveness of doxorubicin and ara-C generally reflected the in vivo clinical response.
    • In vitro inhibition thresholds of 30% for doxorubicin and 20% for ara-C distinguished drug-sensitive from drug-resistant leukemia.
    • The test system detected acquired resistance to chemotherapy during serial testing.
    • No correlation was observed between doxorubicin's in vitro effect and leukemic cell proliferation state.

    Conclusions:

    • The short-term in vitro assay shows promise for predicting individual patient response to specific chemotherapeutic agents in acute leukemia.
    • The method can identify acquired drug resistance, allowing for timely treatment adjustments.
    • The current test format may not be suitable for monitoring combination chemotherapy effects in vitro.